Evaluating the effect of various background correction methods regarding noise reduction, in two-channel microarray data von Sifakis, E.G, Prentza, A, Koutsouris, D, Chatziioannou, A.A

Volltext

223P Gene expression profiles in endocrine-resistant breast cancer von Schagerholm, C., Robertson, S., Sifakis, E.G., Hases, L., Williams, C., Hartman, J.

Volltext

167P The prognostic importance of high HER2 copy numbers and high HER2/CEP17 ratio in trastuzumab-treated early breast cancer von Rönnlund, C., Robertson, S., Sifakis, E.G., Fredriksson, I., Foukakis, T., Hartman, J.

Volltext

4P Longitudinal proteogenomic profiling reveals therapeutic vulnerabilities of immunometabolism in breast cancer von Wang, K., Zerdes, I., Sifakis, E.G., Johansson, H.J., Mezheyeuski, A., Lehtiö, J., Bergh, J., Hatschek, T., Matikas, A., Foukakis, T.

Volltext

68P Application of a machine learning model for identifying an ultra-low risk group of early breast cancer patients von Sarafidis, M., Sifakis, E.G., Bergh, J., Foukakis, T., Matikas, A.

Volltext

1668P Breast cancer patient-derived whole-tumor cell culture model for efficient drug profiling and treatment response prediction von Chen, X., Sifakis, E.G., Robertson, S., Neo, S.Y., Jun, S-H., Tong, L., Lövrot, J., Tay, A., Hellgren, R., Margolin, S., Bergh, J., Foukakis, T., Lagergren, J., Lundqvist, A., Ma, R., Hartman, J.

Volltext

23P Longitudinal evaluation of PAM50 molecular subtypes in patients receiving neoadjuvant HER2-targeted therapy in the PREDIX HER2 trial von Zhu, Y., Sifakis, E.G., Wang, K., Zerdes, I., Bergh, J., Hatschek, T., Matikas, A., Foukakis, T.

Volltext

69P Deep learning prognostication through prediction of TP53 gene mutation status on breast cancer hematoxylin and eosin slides von Tsiknakis, N., Salgkamis, D., Tzoras, E., Wang, K., Liu, X., Manikis, G., Sifakis, E.G., Bergh, J., Marias, K., Zerdes, I., Matikas, A., Foukakis, T.

Volltext

56P Longitudinal circulating plasma protein immune profiling reveals biomarkers of treatment response to neoadjuvant trastuzumab-emtansine (T-DM1) in early HER2-positive breast can... von Zerdes, I., Wang, K., Salgkamis, D., Zhu, Y., Sifakis, E.G., Acs, B., Hartman, J., Hatschek, T., Bergh, J., Matikas, A., Foukakis, T.

Volltext

cDNA microarray analysis of a glucocorticoid treated acute lymphoblastic leukemia cell line von Sifakis, E.G., Lambrou, G.I., Prentza, A., Koutsouris, D., Tzortzatou-Stathopoulou, F.

Volltext bestellen